Tenderwize
Zurück zur Suche

Methotrexaat

VITAZ vzw·Sint-Niklaas, Belgium·EUR 754.7k·Expired · Aug 06, 2026·Open·Supplies·Framework
Registrieren zum SpeichernOpen documents
Structured notice only
Originaltitel der Bekanntmachung

Belgium – Various medicinal products – Methotrexaat

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkExpired
Warum diese Bewertung?

Chance

60 / 100

Komplexität

20 / 100

Risikofaktoren

Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms and obligat...

Strict turnover requirement may deter potential bidders, but also ensures financial capacity.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber
VITAZ vzw
Land
Belgien
CPV
33690000 - Various medicinal products
Frist
Aug 06, 2026
Geschätzter Wert
EUR 754.7k

Überblick

Moderate opportunity

Wichtige Fakten

  • EUR 754.7k estimated value
  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration 48 MONTH
  • Supply of Methotrexaat medicinal products
  • Framework agreement with a single contractor
Vollständige Zusammenfassung anzeigen

This notice is for a 4-year framework agreement for the supply of Methotrexaat medicinal products to Vitaz vzw in Sint-Niklaas, Belgium. The procurement uses an open procedure and is awarded solely on cost (lowest price). Bidders must demonstrate a minimum average annual turnover of €300,000. Only one lot is involved, with a framework maximum value of EUR 754,717. No procurement documents were analyzed, and there is an inconsistency regarding EU funding.

Risiken

Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms and obligat...

Strict turnover requirement may deter potential bidders, but also ensures financial capacity.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Eligibility

  • Minimum average annual turnover of €300,000 over the last three available financial years

Administrative

  • Compliance with the procurement documents (bestek)
  • Electronic submission required via Portal öffnen

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Cost criterion with 100% weight (lowest price) — 100%

Auftraggeber

Ort

Sint-Niklaas, BEL

Auftraggeberprofil

Profil öffnen

Kennung

0881.291.322

Tätigkeit

Health

Lose (1)

LOT-0001

Methotrexaat

Single lot framework agreement for the supply of Methotrexaat medicinal products under an on-call arrangement for 48 months.

SuppliesFrameworkEU fundedElectronic submission

EUR 754.7k

Geschätzter Wert

Ort

Sint-Niklaas, Belgium

Dauer

48 MONTH

Kategorie

Medicinal products

Zuschlagskriterien

Cost

Frist

Expired Aug 06, 2026

Vergabedetails

Veröffentlichungsdatum
01 Jul 2026
Sprachen
Dutch

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
454778-2026

Dokumente (2)

Vergabedokument 1Einreichungsportal 1

Ähnliche Ausschreibungen

Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA

Apr 17

Italy – Various medicinal products – Bando V SDA farmaci

Dec 14

Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД

Oct 31

Italy – Various medicinal products – ARIA_2025_045

Oct 15

Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД

Sep 17

Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione

Jul 18